BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND PTK6, BRK, 5753, ENSG00000101213, Q13882, FLJ42088
10 results:

  • 1. Prospective Series of Transarterial Chemoembolization of Metastatic Colorectal cancer to the liver with 30-60 μm Microspheres Loaded with Irinotecan.
    Malagari K; Kiakidis T; Moschouris H; Charokopakis A; Vergadis C; Alevisopoulos N; Kartsouni V; Panagiotou I; Pellerin O; Glantzounis G; Filippiadis DK; Emmanouil E; Tsavaris N; Psarros G; Delicha E; Kelekis N
    Cardiovasc Intervent Radiol; 2023 Jul; 46(7):880-890. PubMed ID: 37337059
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Src Family Kinases in Hepatocellular Carcinoma.
    Yao D; Deng Y; Zhang S; Liang L; Zhang L; Weng S; Chen S
    Front Biosci (Landmark Ed); 2023 May; 28(5):90. PubMed ID: 37258470
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Single-cell transcriptomics analysis reveals intratumoral heterogeneity and identifies a gene signature associated with prognosis of hepatocellular carcinoma.
    Liang J; Chen W; Ye J; Ni C; Zhai W
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35169832
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression.
    Lang YD; Jou YS
    J Biomed Sci; 2021 Aug; 28(1):57. PubMed ID: 34340703
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PSPC1-interchanged interactions with ptk6 and β-catenin synergize oncogenic subcellular translocations and tumor progression.
    Lang YD; Chen HY; Ho CM; Shih JH; Hsu EC; Shen R; Lee YC; Chen JW; Wu CY; Yeh HW; Chen RH; Jou YS
    Nat Commun; 2019 Dec; 10(1):5716. PubMed ID: 31844057
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effects of Zinc Acetate on Serum Zinc Concentrations in Chronic liver Diseases: a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial and a Dose Adjustment Trial.
    Katayama K; Hosui A; Sakai Y; Itou M; Matsuzaki Y; Takamori Y; Hosho K; Tsuru T; Takikawa Y; Michitaka K; Ogawa E; Miyoshi Y; Ito T; Ida S; Hamada I; Miyoshi K; Kodama H; Takehara T
    Biol Trace Elem Res; 2020 May; 195(1):71-81. PubMed ID: 31392541
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
    Goel RK; Lukong KE
    Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Breast tumor kinase/protein tyrosine kinase 6 (brk/ptk6) activity in normal and neoplastic biliary epithelia.
    Mizuguchi Y; Specht S; Isse K; Sasatomi E; Lunz JG; Takizawa T; Demetris AJ
    J Hepatol; 2015 Aug; 63(2):399-407. PubMed ID: 25770659
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ptk6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
    Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
    Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa.
    Chen WS; Kung HJ; Yang WK; Lin Wc
    Int J Cancer; 1999 Nov; 83(5):579-84. PubMed ID: 10521789
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.